WASHINGTON // Federal officials have undermined the national program to find medicines to protect Americans against chemical, biological or radiological attacks, the head of a San Diego biotechnology company will tell Congress today.Richard B. Hollis, chief executive of Hollis-Eden Pharmaceuticals Inc., whose anti-radiation drug was rejected by the government, plans to tell legislators that his company “will never again seek to work with the government.”>>> Discuss This Story
